耳部基底细胞癌Mohs 显微外科手术与放射治疗的复发率比较。

Recurrence Rates of Mohs Micrographic Surgery vs Radiation Therapy for Basal Cell Carcinoma of the Ear.

机构信息

Drs. Clements, Tripuraneni, Kelley, and Greenway are from Bighorn Mohs Surgery and Dermatology Center, Scripps Clinic, San Diego, California. Dr. Jeha is from the Department of Dermatology, Louisiana State University Health Sciences Center, New Orleans.

出版信息

Cutis. 2024 May;113(5):216-217. doi: 10.12788/cutis.1004.

DOI:10.12788/cutis.1004

PMID:39042118

Abstract

Basal cell carcinoma (BCC) of the ear may have aggressive histologic subtypes and a greater propensity for subclinical spread than BCC in other anatomic locations. In this retrospective analysis, we evaluated recurrence rates of BCC of the ear in 102 patients who underwent treatment with Mohs micrographic surgery (MMS) or radiation therapy (RT) at a single institution between January 2017 and December 2019. Data on patient demographics, tumor characteristics, treatment modality, and recurrence rates were collected from medical records. Recurrence rates were assessed over a mean follow-up time of 2.8 years. Although MMS is the gold standard for treatment of BCC of the ear, RT may be a suitable alternative for nonsurgical candidates.

摘要

耳部基底细胞癌（BCC）可能具有侵袭性组织学亚型，并且比其他解剖部位的 BCC 更容易发生亚临床扩散。在这项回顾性分析中，我们评估了 102 例在单一机构接受 Mohs 显微外科手术（MMS）或放射治疗（RT）治疗的耳部 BCC 患者的复发率，这些患者的治疗时间在 2017 年 1 月至 2019 年 12 月之间。从病历中收集了患者人口统计学、肿瘤特征、治疗方式和复发率的数据。平均随访时间为 2.8 年，评估了复发率。虽然 MMS 是耳部 BCC 的金标准治疗方法，但 RT 可能是不适合手术患者的合适替代方法。